{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:03:21Z","timestamp":1793657001525,"version":"4.5.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ekir.2022.09.012","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:48:32Z","timestamp":1663415312000},"page":"2647-2656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis"],"prefix":"10.1016","volume":"7","author":[{"given":"Giovanni Maria","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Peyronel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paride","family":"Fenaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Delsante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Daniele","family":"Benigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gianfreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Letizia","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerai","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois Johanna","family":"Arend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fiaccadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfaraz","family":"Hasni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Manenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2022.09.012_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.ekir.2022.09.012_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/kel039","article-title":"An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period","volume":"45","author":"Adler","year":"2006","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.ekir.2022.09.012_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.ekir.2022.09.012_bib4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","article-title":"Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis","volume":"77","author":"Moroni","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ekir.2022.09.012_bib5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.semnephrol.2015.08.011","article-title":"ESKD, transplantation, and dialysis in lupus nephritis","volume":"35","author":"Sabucedo","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib6","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.30293","article-title":"Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006","volume":"63","author":"Costenbader","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ekir.2022.09.012_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/sdi.12122","article-title":"Improving outcomes in patients with lupus and end-stage renal disease","volume":"26","author":"Inda-Filho","year":"2013","journal-title":"Semin Dial"},{"key":"10.1016\/j.ekir.2022.09.012_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/annrheumdis-2020-216965","article-title":"Lack of EULAR\/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis","volume":"79","author":"Moroni","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ekir.2022.09.012_bib9","first-page":"302","article-title":"Prolonged hypocomplementemia in poststreptococcal acute glomerulonephritis","volume":"46","author":"Dedeoglu","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2012.384","article-title":"Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement","volume":"83","author":"Sethi","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.09.012_bib11","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3389\/fimmu.2018.02329","article-title":"Unraveling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN","volume":"9","author":"Donadelli","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2022.09.012_bib12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2022.09.012_bib13","doi-asserted-by":"crossref","first-page":"25343","DOI":"10.1074\/jbc.M115.647008","article-title":"Functional characterization of autoantibodies against complement Component C3 in patients with lupus nephritis","volume":"290","author":"Vasilev","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ekir.2022.09.012_bib14","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ekir.2022.09.012_bib15","first-page":"1907","article-title":"Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus","volume":"34","author":"Alkhatib","year":"2021","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ekir.2022.09.012_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2022.09.012_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.09.012_bib20","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2022.09.012_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2016.00036","article-title":"Early components of the complement classical activation pathway in human systemic autoimmune diseases","volume":"7","author":"Lintner","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2022.09.012_bib22","series-title":"Joint Models for Longitudinal and Time-to-Event Data: With Applications in R","author":"Rizopoulos","year":"2012"},{"key":"10.1016\/j.ekir.2022.09.012_bib23","author":"Rizopoulos"},{"key":"10.1016\/j.ekir.2022.09.012_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.semarthrit.2020.06.009","article-title":"The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort","volume":"50","author":"Durcan","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ekir.2022.09.012_bib25","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.ekir.2022.09.012_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0272-6386(12)80609-3","article-title":"Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The lupus Nephritis Collaborative Study Group","volume":"18","author":"Ricker","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.09.012_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0002-9343(78)90056-6","article-title":"The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study","volume":"64","author":"Appel","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.ekir.2022.09.012_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3899\/jrheum.191094","article-title":"Risk of renal failure within 10 or 20 years of systemic lupus erythematosus diagnosis","volume":"48","author":"Petri","year":"2021","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ekir.2022.09.012_bib29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2006090992","article-title":"Severe lupus nephritis: racial differences in presentation and outcome","volume":"18","author":"Korbet","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0961203314567751","article-title":"Renal outcomes among Egyptian lupus nephritis patients: a retrospective analysis of 135 cases from a single centre","volume":"24","author":"Mahmoud","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.ekir.2022.09.012_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1994.70","article-title":"Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data","volume":"45","author":"Austin","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.09.012_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ekir.2022.09.012_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/acr.20116","article-title":"Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis","volume":"62","author":"Faurschou","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ekir.2022.09.012_bib34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2215\/CJN.10601016","article-title":"Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis","volume":"12","author":"Rijnink","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amjms.2017.01.005","article-title":"Complement alternative pathways activation in patients with lupus nephritis","volume":"353","author":"Song","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ekir.2022.09.012_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.03990415","article-title":"Relationship of circulating anti-C3b and anti-C1q IgG to lupus nephritis and its flare","volume":"11","author":"Birmingham","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1681\/ASN.2019080851","article-title":"Anti-factor B antibodies and acute postinfectious GN in children","volume":"31","author":"Chauvet","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.09.012_bib38","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3899\/jrheum.180773","article-title":"Clinical outcomes and clinico-pathological correlations in lupus nephritis with kidney biopsy showing thrombotic microangiopathy","volume":"46","author":"Li","year":"2019","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ekir.2022.09.012_bib39","first-page":"1147","article-title":"Renal thrombotic microangiopathy associated to worse renal prognosis in lupus Nephritis","volume":"34","author":"Strufaldi","year":"2021","journal-title":"J\u00a0Nephrol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922017739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922017739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:43:28Z","timestamp":1762832608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024922017739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2468024922017739"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2022.09.012","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2022.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}